Go Pro

Lexaria Bioscience (LEXX) Insider Trading & Ownership

Lexaria Bioscience logo
$5.22 +0.47 (+9.89%)
As of 02:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Lexaria Bioscience (NASDAQ:LEXX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.39%
Number Of
Insiders Buying
(Last 3 Years)
6
Amount Of
Insider Buying
(Last 3 Years)
$105.13K
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$10.26K
Get LEXX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexaria Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LEXX Insider Buying and Selling by Quarter

Lexaria Bioscience Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/30/2025
Christopher Bunka
Director
Buy793$13.65$10,824.45  
7/29/2025
Christopher Bunka
Director
Buy1,040$13.80$14,352.00  
7/29/2025
John Martin Docherty
Insider
Buy358$13.95$4,994.10  
7/29/2025
Richard Christopher
CEO
Buy1,000$13.65$13,650.00  
7/29/2025
Vanessa Carle
Insider
Buy50$13.65$682.50  
7/29/2025
William Edward Mckechnie
Director
Buy333$13.65$4,545.45  
12/2/2024
Richard Christopher
CEO
Buy1,521$33.60$51,105.60  
8/12/2024
Catherine C Turkel
Director
Buy106$46.95$4,976.70  
7/31/2024
Vanessa Carle
insider
Sell171$60.00$10,260.00  
(Data available from 1/1/2013 forward)

LEXX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Lexaria Bioscience includes Catherine C Turkel, Christopher Bunka, John Martin Docherty, Richard Christopher, Vanessa Carle, and William Edward Mckechnie. Learn more on insiders at LEXX.

8.39% of Lexaria Bioscience stock is owned by insiders. Learn more on LEXX's insider holdings.

The following insiders have purchased LEXX shares in the last 24 months: Catherine C Turkel ($4,976.70), Christopher Bunka ($25,176.45), John Martin Docherty ($4,994.10), Richard Christopher ($64,755.60), Vanessa Carle ($682.50), and William Edward Mckechnie ($4,545.45).

Insiders have purchased a total of 5,201 LEXX shares in the last 24 months for a total of $105,130.80 bought.



This page (NASDAQ:LEXX) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners